Cigna Corporation (CI)
| Market Cap | 97.52B |
| Revenue (ttm) | 206.00B |
| Net Income (ttm) | 3.62B |
| Shares Out | 284.07M |
| EPS (ttm) | 12.19 |
| PE Ratio | 28.16 |
| Forward PE | 11.38 |
| Dividend | $5.60 (1.63%) |
| Ex-Dividend Date | Jun 4, 2024 |
| Volume | 1,749,370 |
| Open | 345.00 |
| Previous Close | 346.42 |
| Day's Range | 342.08 - 345.62 |
| 52-Week Range | 240.50 - 365.71 |
| Beta | 0.58 |
| Analysts | Strong Buy |
| Price Target | 370.82 (+8.02%) |
| Earnings Date | May 2, 2024 |
About CI
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other product... [Read more]
Financial Performance
In 2023, Cigna's revenue was $195.27 billion, an increase of 8.17% compared to the previous year's $180.52 billion. Earnings were $5.16 billion, a decrease of -22.97%.
Financial StatementsAnalyst Forecast
According to 18 analysts, the average rating for CI stock is "Strong Buy." The 12-month stock price forecast is $370.82, which is an increase of 8.02% from the latest price.
News
The Cigna Group Ranks No. 7 in Fair360 Top 50 Companies
Overall ranking increased seven spots from 2023, reflecting the enterprise's actions to bolster the vitality of The Cigna Group's workforce and the communities it serves BLOOMFIELD, Conn. , May 14, 20...
Cigna's stock jumps 2.7% after earnings beat estimates and company raises guidance
Cigna Group's stock CI, +0.04% rose 2.7% early Thursday, after the healthcare and insurance company posted better-than-expected first-quarter earnings and raised its guidance. The company had a net lo...
Cigna sees strong annual profit on lower costs, pharmacy benefit strength
Health insurer Cigna Group raised its annual profit forecast on Thursday, as lower-than-expected medical costs and strength in its pharmacy benefit management unit helped it beat first-quarter earning...
The Cigna Group Reports Strong First Quarter 2024 Results, Raises 2024 Outlook
Total revenues for the first quarter 2024 were $57.3 billion Shareholders' net loss for the first quarter 2024 was $0.3 billion, or $0.97 per share Adjusted income from operations1 for the first quart...
Cigna Suffers $300 Million Loss As VillageMD Clinic Investment Reels
The Cigna Group reported a $300 million first quarter loss as the company's Evernorth health services business grapples with the loss in value of its investment in doctor-staffed clinic operator Villa...
New Report: Employers Play Critical Role in Curbing Today's Youth Mental Health Crisis
Declining youth mental health persists, and many young people receive fragmented care Managing a child's mental health needs significantly impacts working parents, both personally and professionally O...
Cigna to offer Humira rivals with $0 copay at specialty pharmacy
Cigna plans to make close copies of AbbVie's blockbuster arthritis drug Humira available with no out-of-pocket payment to eligible patients in the U.S. using its specialty pharmacy beginning in June, ...
Evernorth announces Humira biosimilar available at $0 out of pocket for Accredo patients in June
High- and low-concentration interchangeable biosimilar will be available, estimated to save individual patients around $3,500 on average per year Biosimilar price will be about 85% lower than Humira®...
The Cigna Group Declares Quarterly Dividend
BLOOMFIELD, Conn. , April 24, 2024 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE: CI) today declared a cash dividend of $1.40 per share of its common stock, payable on June 20, 2024 ...
FTC looking to accelerate inquiry into prescription-drug middlemen, chair says
The Federal Trade Commission is working to accelerate its inquiry into the prescription-drug middlemen known as pharmacy-benefit managers, while also expanding its scrutiny of drug patents that can ke...
The Cigna Group Announces Appearance at the BofA Securities 2024 Health Care Conference
BLOOMFIELD, Conn. , April 23, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced today that Brian Evanko, executive vice president and chief financial officer, will present...
The Cigna Group Foundation Announces New Grant Program To Address Youth Mental Health Crisis
Grant application now open for nonprofits that aim to improve youth mental health New multiyear philanthropic and community engagement initiative will also prioritize the mental health of veterans th...
The Cigna Group's First Quarter 2024 Earnings Release Details
BLOOMFIELD, Conn. , April 11, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its first quarter 2024 financial results on Thursday, May 2, 2024, and will host a confe...
The Cigna Group Named Among Best Employers for Health and Well-Being
Company Recognized for Excellence in Health Equity BLOOMFIELD, Conn. , April 9, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) has been recognized for excellence in empl...
Outperforming ETF manager names a potential ‘50-bagger' in the stock market
The Simplify Health Care exchange-traded fund has grown to $136 million in assets in two and a half years. It is never easy for an actively managed fund to outperform its benchmark or a broad stock-ma...
Pacific Prime Wins Cigna Global's Top Producing Broker Asia Award 2024
SYDNEY--(BUSINESS WIRE)--Global health insurance brokerage Pacific Prime Dubai has been awarded the Top Producing Broker Asia Award by Cigna at the Global Broker Advisory Council (GBAC) Awards, held i...
Health care stocks headed for worst day since early November
CNBC's Bertha Coombs reports on what's driving health insurer stocks lower.
Cigna CEO on medicare advantage and GLP-1 access program
Cigna CEO David Cordani joins 'The Exchange' with CNBC's Bertha Coombs to discuss the company's growth opportunity in services, Cigna's GLP-1 access program, and more.
Cigna Strikes Deals To Limit Cost of Weight-Loss Drugs
Cigna Group (CI) said it has taken steps to control the cost and increase coverage of diabetes and weight-loss medicines, which have experienced a boom in demand by those looking to shed pounds.
Cigna launches effort to cap employer insurance plan spending on weight loss drugs
Cigna's Evernorth struck agreements with Novo Nordisk and Eli Lilly to limit spending increases for those GLP-1s to a maximum of 15% annually.
Cigna launches program to help clients manage high costs from weight-loss drugs boom
Cigna Group said on Thursday its pharmacy benefit management unit had launched a new program aimed at limiting spending on weight-loss drugs by its health insurance clients, which plan to cover the me...
The Cigna Group Raises Long-Term Growth Target, and Launches New Innovative Solutions at 2024 Investor Day
Highlights: Raises long-term average annual adjusted EPS1 growth target to 10%-14% Affirms 2024 adjusted EPS1 guidance of at least $28.25 Announces solutions and innovations for some of the greatest h...
Cigna's Evernorth To Launch Behavioral Health Practice Group
Cigna's Evernorth Health Services is launching an outpatient behavioral health practice as health insurers and healthcare providers integrate mental health services with medical care to better address...
Pacific Prime Wins Cigna's Top Producer 2023 Individuals Award
DUBAI, United Arab Emirates--(BUSINESS WIRE)--Global health insurance brokerage Pacific Prime Dubai has been awarded Top Producer 2023 Individuals with Cigna for their excellent performance in Dubai u...